Ki-67 and Bcl-2 in colorectal polyps with breast cancer

Background: The most common second primary cancer in women who survive breast cancer is colorectal cancer. Population cohort studies suggest that the risk of colorectal cancer is also high in female relatives of women with breast cancer compared to the general population. The histological distinctio...

Full description

Bibliographic Details
Main Author: Ibrahim Gelincik
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2011-01-01
Series:Indian Journal of Pathology and Microbiology
Subjects:
Online Access:http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=2;spage=307;epage=311;aulast=Gelincik
id doaj-d6bb1b29f11045c1b220c26cdeb4e245
record_format Article
spelling doaj-d6bb1b29f11045c1b220c26cdeb4e2452020-11-25T00:16:00ZengWolters Kluwer Medknow PublicationsIndian Journal of Pathology and Microbiology0377-49292011-01-0154230731110.4103/0377-4929.81608Ki-67 and Bcl-2 in colorectal polyps with breast cancerIbrahim GelincikBackground: The most common second primary cancer in women who survive breast cancer is colorectal cancer. Population cohort studies suggest that the risk of colorectal cancer is also high in female relatives of women with breast cancer compared to the general population. The histological distinction between a large hyperplastic polyp and a serrated adenoma is not straightforward and there is probably no sharp division between hyperplastic polyposis and ′serrated adenomatous polyposis′. Aim: The aim of the study was to define the distribution of Ki-67 and Bcl-2 protein in hyperplastic colorectal polyps of women with breast cancer. Materials and Methods: A cross-sectional, controlled study was conducted in 40 women with and without breast cancer who had hyperplastic colorectal polyps. The patients were divided into two groups: Group A (a control group of women without breast cancer, n = 20) and Group B (a study group of women with breast cancer, n = 20). The expression of Ki-67 and Bcl-2 protein was assessed on the basis of quantity of immunostaining, by counting antigen positive cells, in comparison with normal mucosa. Student′s t-test and the chi-square test were used to analyse Ki-67 and Bcl-2 expression, respectively. Results: Statistical significance was established at P < 0.05. The mean percentage of Ki-67 stained nuclei in Groups A and B was 25.11 ± 2.07 and 41.51 ± 1.86, respectively (P < 0.003), whereas the percentage of cases with cells expressing Bcl-2 in Groups A and B was 15% and 85%, respectively (P < 0.002). Conclusions: In the present study, greater proliferative activity and greater expression of the antiapoptotic protein Bcl-2 was found in the hyperplastic colorectal polyps of women with breast cancer.http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=2;spage=307;epage=311;aulast=GelincikBcl-2breast cancerhyperplastic colorectal polypsKi-67
collection DOAJ
language English
format Article
sources DOAJ
author Ibrahim Gelincik
spellingShingle Ibrahim Gelincik
Ki-67 and Bcl-2 in colorectal polyps with breast cancer
Indian Journal of Pathology and Microbiology
Bcl-2
breast cancer
hyperplastic colorectal polyps
Ki-67
author_facet Ibrahim Gelincik
author_sort Ibrahim Gelincik
title Ki-67 and Bcl-2 in colorectal polyps with breast cancer
title_short Ki-67 and Bcl-2 in colorectal polyps with breast cancer
title_full Ki-67 and Bcl-2 in colorectal polyps with breast cancer
title_fullStr Ki-67 and Bcl-2 in colorectal polyps with breast cancer
title_full_unstemmed Ki-67 and Bcl-2 in colorectal polyps with breast cancer
title_sort ki-67 and bcl-2 in colorectal polyps with breast cancer
publisher Wolters Kluwer Medknow Publications
series Indian Journal of Pathology and Microbiology
issn 0377-4929
publishDate 2011-01-01
description Background: The most common second primary cancer in women who survive breast cancer is colorectal cancer. Population cohort studies suggest that the risk of colorectal cancer is also high in female relatives of women with breast cancer compared to the general population. The histological distinction between a large hyperplastic polyp and a serrated adenoma is not straightforward and there is probably no sharp division between hyperplastic polyposis and ′serrated adenomatous polyposis′. Aim: The aim of the study was to define the distribution of Ki-67 and Bcl-2 protein in hyperplastic colorectal polyps of women with breast cancer. Materials and Methods: A cross-sectional, controlled study was conducted in 40 women with and without breast cancer who had hyperplastic colorectal polyps. The patients were divided into two groups: Group A (a control group of women without breast cancer, n = 20) and Group B (a study group of women with breast cancer, n = 20). The expression of Ki-67 and Bcl-2 protein was assessed on the basis of quantity of immunostaining, by counting antigen positive cells, in comparison with normal mucosa. Student′s t-test and the chi-square test were used to analyse Ki-67 and Bcl-2 expression, respectively. Results: Statistical significance was established at P < 0.05. The mean percentage of Ki-67 stained nuclei in Groups A and B was 25.11 ± 2.07 and 41.51 ± 1.86, respectively (P < 0.003), whereas the percentage of cases with cells expressing Bcl-2 in Groups A and B was 15% and 85%, respectively (P < 0.002). Conclusions: In the present study, greater proliferative activity and greater expression of the antiapoptotic protein Bcl-2 was found in the hyperplastic colorectal polyps of women with breast cancer.
topic Bcl-2
breast cancer
hyperplastic colorectal polyps
Ki-67
url http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2011;volume=54;issue=2;spage=307;epage=311;aulast=Gelincik
work_keys_str_mv AT ibrahimgelincik ki67andbcl2incolorectalpolypswithbreastcancer
_version_ 1725385268343603200